InformexUSA, San Francisco (Feb. 14)-Almac Sciences plans to collaborate for cytotoxic fill-and-finish services with the Center for Pharmaceutical Science and Technology (CPST) at the University of ...

Almac Sciences has this year announced details of its “First in Man” approach to peptide synthesis. This embraces and offers development of peptide synthesis, full analytical support (including method ...

Almac Group has completed a multi-million-pound expansion of its bioavailability enhancement capabilities at its facility in Charnwood, UK. The significant investment by Almac Pharma Services, will ...

Almac has announced a £16m expansion of its pharmaceutical services creating 180 jobs at its new facility in England. The Craigavon-based group, has said the investment would expand its formulation ...

Almac is investing GBP16 million to expand its formulation and analytical development services and has successfully negotiated to operate in the Charnwood Campus in Loughborough, England. The CDMO ...

The Almac Group has today announced an £11m investment and the creation of over 100 new jobs to expand its global analytical services capabilities. Over the past 18 months, Almac Sciences and Almac ...

PHARMA and diagnostics giant Almac doubled its operating profits to nearly £29 million in 2015 - easily the most successful trading year in its short history. Figures filed at Companies House also ...

Almac’s sciences and pharma services divisions have jointly made the investment to expand their existing analytical laboratories, technology and resource to meet ongoing global demand. Almac employs ...

Almac, the Northern Ireland pharmaceutical firm based in Craigavon, is to open its first facility in England and create 180 jobs. The firm said it would operate from "a significant proportion" of the ...

Almac, the Northern Ireland pharmaceutical firm based in Craigavon, is to open its first facility in England and create 180 jobs. The firm said it would operate from "a significant proportion" of the ...